Gastric ulcer recurrence: Foliow-up of a double-blind, placebo-controlled trial

J. D. Wolosin, S. L. Gertler, W. L. Peterson, M. A. Sandersfeld, J. I. Isenberg

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Following a multicenter, double-blind trial comparing ci-metidine, antacid, and placebo for the treatment of gastric ulcer, patients whose ulcers had healed were followed prospectively to assess the frequency of ulcer relapse. Fifty-eight patients entered the follow-up study. Patients were encouraged to discontinue smoking and excessive ethanol intake, but were not maintained on antiulcer medications. Clinical evaluation was performed at monthly intervals; repeat en-doscopy was performed at the time of symptom recurrence or at 6 to 9 months after ulcer healing. Gastric ulcer recurred in 20 of 58 patients (35%). While 15 (75%) with ulcer recurrence had symptoms, 5 (25%) had asymptomatic recurrences. There were no differences in the incidence of ulcer relapse or symptom recurrences between groups. We conclude that gastric ulcers recur in approximately one-third of patients within 9 months of ulcer healing.

Original languageEnglish (US)
Pages (from-to)12-16
Number of pages5
JournalJournal of Clinical Gastroenterology
Issue number1
StatePublished - Feb 1989


  • Antacids
  • Cimetidine
  • Clinical trials
  • Gastric ulcer
  • Placebo

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Gastric ulcer recurrence: Foliow-up of a double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Cite this